Tumor immune escape by immunoregulatory CD4 T cells
Tumor immune escape by immunoregulatory CD4 T cells
批准号:
10670304
负责人:
NAKAYAMA Eiichi
金额:
$1.79万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
癌症免疫监测理论已经被广泛接受,但科学基础仍然是模糊的。肿瘤免疫逃逸也是一个关于任何机制的理论,它并不完全过时。最近,通过宿主免疫系统识别的肿瘤抗原已在分子水平上识别,以及对肿瘤免疫学的肿瘤免疫反应的分析,免疫监测的理论和肿瘤免疫逃逸应该被谨慎地重新评价。在本研究中,使用BALB/c辐射白血病RL 1关于我们以前在哪里已经识别的特异性肽识别的特异CTL作为模型肿瘤,我们已识别的肿瘤或抗原特异性调节CD 4 T细胞。We showed that altered Akt molecule which is dominant antigen in RL?1刺激免疫抑制因子CD4T cells and inhibited efficient generation of CD8CTL which recognized the tumor antigen peptide derived also from the Akt molecule.Beside those tumor antigen specific regulatory CD4T cells, we also found immunoregulatory CD4イD1+イD1T cells which were tumor antigen non-specific.这些细胞是由自动抗原激活的,并受自动免疫保护。We showed that by in vivo depletion of CD4イイD1+イエD1 CD25イイD1+イエD1 T cells, efficient tumor rejection res隅occurred。
英文摘要
Cancer immune surveillance theory has been widely accepted, but the scientific basis is still obscure. Tumor immune escape is also a theory of which mechanisms have not fully elucidated. Recently, tumor antigens recognized by the host immune system have been identified at molecular level, and the analysis of tumor immune responses against the tumor immunology, theories of the immune surveillance and the tumor immune escape should be carefully reevaluated.In this study, using BALB/c radiation leukemia RL♂1 on which we previously identified the antigen peptide recognized by the specific CTL as a model tumor, we identified tumor antigen specific regulatory CD4 T cells. We showed that altered Akt molecule which is dominant antigen in RL♂1 stimulated immunoregulatory CD4 T cells and inhibited efficient generation of CD8 CTL which recognized the tumor antigen peptide derived also from the Akt molecule.Beside those tumor antigen specific regulatory CD4 T cells, we also found immunoregulatory CD4ィイD1+ィエD1CD25ィイD1+ィエD1 T cells which were tumor antigen non-specific. Those cells were activated by autoantigens and protected from auto immunity. We showed that by in vivo depletion of CD4ィイD1+ィエD1CD25ィイD1+ィエD1 T cells, efficient tumor rejection response occurred.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Shibuya, A., et al.: "Physical and functional association of LFA-1 with DNAM-1 adhesion molecule"Immunity. 11. 615-623 (1999)
Shibuya, A. 等人:“LFA-1 与 DNAM-1 粘附分子的物理和功能关联”免疫。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kobayashi, Y., et al.: "Expression of MAGE, GAGE and BAGE genes in human liver diseases: utility as molecular markers for hepatocellular carcinoma"J. Hepatol.. (in press).
Kobayashi, Y., et al.:“MAGE、GAGE 和 BAGE 基因在人类肝脏疾病中的表达:作为肝细胞癌分子标记的实用性”J.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takaki, T., et al.: "Variable expression on lung cancer cell lines of HLA-A2-binding MAGE-3 peptide recognized by cytotoxic T lymphocytes." Int. J. Oncol.12. 1103-1109 (1998)
Takaki, T. 等人:“细胞毒性 T 淋巴细胞识别的 HLA-A2 结合 MAGE-3 肽在肺癌细胞系上的可变表达。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kariyama, K., et al.: "Expression of MAGE-1 and -3 genes and gene products in human hepatocellular carcinoma"British J. Cancer. 81. 1080-1087 (1999)
Kariyama,K.等人:“人肝细胞癌中MAGE-1和-3基因及基因产物的表达”British J. Cancer。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Honda, S., et al: "Possible involvement of autoreactive CD4 T cells in generation of cytotoxic T lymphocytes on in vitro stimulation with H-2 class I-binding tumor antigen peptide." Int. immunol.10. 1167-1174 (1998)
Honda, S. 等人:“在体外用 H-2 I 类结合肿瘤抗原肽刺激时,自身反应性 CD4 T 细胞可能参与细胞毒性 T 淋巴细胞的生成。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 14 条
Use of long overlapping peptides for cancer vaccine and Treg control for potentiating immune response
-
批准号:22300332
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.32万
-
财政年份:2010
-
负责人:NAKAYAMA Eiichi
-
依托单位:
Analysis of human tumor antigens and immune responses in patients
-
批准号:17016048
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$47.68万
-
财政年份:2005
-
负责人:NAKAYAMA Eiichi
-
依托单位:
Tumor immune escape and the role of CD4 regulatory T cells
-
批准号:13670319
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$0.7万
-
财政年份:2001
-
负责人:NAKAYAMA Eiichi
-
依托单位:
Induction of immune response against MHC class I-binding peptides
-
批准号:07670372
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1995
-
负责人:NAKAYAMA Eiichi
-
依托单位:
Cellular mechanisms of graft rejection mediated by CD4-CD8-TCR alphabeta T cells.
-
批准号:04454210
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$0.77万
-
财政年份:1992
-
负责人:NAKAYAMA Eiichi
-
依托单位:
Proliferation of double negative (DN) gammadelta T cells in reseponse to allogeneic MHC antigen.
-
批准号:02670206
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1990
-
负责人:NAKAYAMA Eiichi
-
依托单位:
海外基金